These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16969268)

  • 1. Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association.
    Rippel CA; Kobets AJ; Yoon DY; Williams PN; Shugart YY; Bridges DD; Vandenbergh DJ; Singer HS
    Psychiatr Genet; 2006 Oct; 16(5):179-80. PubMed ID: 16969268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional gene variation in the human norepinephrine transporter: association with attention deficit hyperactivity disorder.
    Kim CH; Waldman ID; Blakely RD; Kim KS
    Ann N Y Acad Sci; 2008; 1129():256-60. PubMed ID: 18591486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD).
    Ramoz N; Boni C; Downing AM; Close SL; Peters SL; Prokop AM; Allen AJ; Hamon M; Purper-Ouakil D; Gorwood P
    Neuropsychopharmacology; 2009 Aug; 34(9):2135-42. PubMed ID: 19387424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of intronic variants of the BTBD9 gene with Tourette syndrome.
    Rivière JB; Xiong L; Levchenko A; St-Onge J; Gaspar C; Dion Y; Lespérance P; Tellier G; Richer F; Chouinard S; Rouleau GA;
    Arch Neurol; 2009 Oct; 66(10):1267-72. PubMed ID: 19822783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence for association between a functional promoter variant of the Norepinephrine Transporter gene SLC6A2 and ADHD in a family-based sample.
    Renner TJ; Nguyen TT; Romanos M; Walitza S; Röser C; Reif A; Schäfer H; Warnke A; Gerlach M; Lesch KP
    Atten Defic Hyperact Disord; 2011 Sep; 3(3):285-9. PubMed ID: 21739117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between response of OROS-methylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHD.
    Lee SH; Kim SW; Lee MG; Yook KH; Greenhill LL; Fradin KN; Hong HJ
    Psychiatry Res; 2011 Apr; 186(2-3):338-44. PubMed ID: 20863575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No causal role for the G482T and G689T polymorphisms in translation regulation of serotonin transporter (SLC6A4) or association with attention-deficit-hyperactivity disorder (ADHD).
    Banerjee E; Sinha S; Chatterjee A; Nandagopal K
    Neurosci Lett; 2009 May; 454(3):244-8. PubMed ID: 19429092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norepinephrine transporter polymorphisms T-182C and G1287A are not associated with alcohol dependence and its clinical subgroups.
    Huang SY; Lu RB; Ma KH; Shy MJ; Lin WW
    Drug Alcohol Depend; 2008 Jan; 92(1-3):20-6. PubMed ID: 17630229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication of an association of a promoter polymorphism of the dopamine transporter gene and Attention Deficit Hyperactivity Disorder.
    Doyle C; Brookes K; Simpson J; Park J; Scott S; Coghill DR; Hawi Z; Kirley A; Gill M; Kent L
    Neurosci Lett; 2009 Sep; 462(2):179-81. PubMed ID: 19576958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample.
    Laucht M; Skowronek MH; Becker K; Schmidt MH; Esser G; Schulze TG; Rietschel M
    Arch Gen Psychiatry; 2007 May; 64(5):585-90. PubMed ID: 17485610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case-control association study of the polymorphism at the promoter region of the DRD4 gene in Korean boys with attention deficit-hyperactivity disorder: evidence of association with the -521 C/T SNP.
    Yang JW; Jang WS; Hong SD; Ji YI; Kim DH; Park J; Kim SW; Joung YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):243-8. PubMed ID: 17850946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence of linkage or association between the norepinephrine transporter (NET) gene polymorphisms and ADHD in the Irish population.
    McEvoy B; Hawi Z; Fitzgerald M; Gill M
    Am J Med Genet; 2002 Aug; 114(6):665-6. PubMed ID: 12210284
    [No Abstract]   [Full Text] [Related]  

  • 13. Association analysis of serotonin transporter promoter gene polymorphism with ADHD and related symptomatology.
    Zhao AL; Su LY; Zhang YH; Tang BS; Luo XR; Huang CX; Su QR
    Int J Neurosci; 2005 Aug; 115(8):1183-91. PubMed ID: 16040360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between major depressive disorder and the norepinephrine transporter polymorphisms T-182C and G1287A: a meta-analysis.
    Zhao X; Huang Y; Ma H; Jin Q; Wang Y; Zhu G
    J Affect Disord; 2013 Aug; 150(1):23-8. PubMed ID: 23648227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation screening of the dopamine D1 receptor gene in Tourette's syndrome and alcohol dependent patients.
    Thompson M; Comings DE; Feder L; George SR; O'Dowd BF
    Am J Med Genet; 1998 May; 81(3):241-4. PubMed ID: 9603612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder.
    Park S; Kim JW; Yang YH; Hong SB; Park MH; Kim BN; Shin MS; Yoo HJ; Cho SC
    Behav Brain Funct; 2012 May; 8():22. PubMed ID: 22591463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin and the biochemical genetics of alcoholism: lessons from studies of attention deficit hyperactivity disorder (ADHD) and Tourette syndrome.
    Comings DE
    Alcohol Alcohol Suppl; 1993; 2():237-41. PubMed ID: 7748306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder.
    Kim CH; Hahn MK; Joung Y; Anderson SL; Steele AH; Mazei-Robinson MS; Gizer I; Teicher MH; Cohen BM; Robertson D; Waldman ID; Blakely RD; Kim KS
    Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19164-9. PubMed ID: 17146058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An individual with Gilles de la Tourette syndrome and Smith-Magenis microdeletion syndrome: is chromosome 17p11.2 a candidate region for Tourette syndrome putative susceptibility genes?
    Shelley BP; Robertson MM; Turk J
    J Intellect Disabil Res; 2007 Aug; 51(Pt 8):620-4. PubMed ID: 17598875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the dopamine D4 receptor gene variants in attention deficit hyperactivity disorder].
    Kereszturi E; Király O; Csapó Z; Tárnok Z; Gádoros J; Sasvári-Székely M; Nemoda Z
    Neuropsychopharmacol Hung; 2007 Mar; 9(1):11-8. PubMed ID: 17879560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.